Top Markets
#1 Black Phoenix Black Phoenix +354.53%
#2 Glidr Glidr +84.34%
#3 Gold Park Gold Park +55.15%
#4 Akedo Akedo +52.53%
#5 Acurast Acurast +33.26%
#6 BasedHype BasedHype +27.64%
#7 Cryptopia Cryptopia +21.54%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +19.45%
#9 Avantis Avantis +18.91%
#10 HOME HOME +14.74%
Coin of the day
Black Phoenix Black Phoenix
Inställningar
Språk
SVENSKA
Valuta
USD
Tema
Amarantus BioScience Holdings, Inc. Amarantus BioScience Holdings, Inc.

Amarantus BioScience Holdings, Inc.

AMBS
Rankning i aktier #41180
Amarantus BioScience Holdings, Inc. operates as a biopharmaceutical firm,... Amarantus BioScience Holdings, Inc. operates as a biopharmaceutical firm, concentrating on creating innovative diagnostic tools and therapeutic solutions. Its primary focus areas encompass neurological disorders, psychiatric conditions, eye-related ailments (ophthalmology), and regenerative medicine. The company's diagnostic pipeline includes the LymPro test, a blood-based diagnostic designed to detect Alzheimer's disease by analyzing lymphocyte proliferation, and MSPrecise, a proprietary DNA sequencing assay aimed at identifying individuals with multiple sclerosis. On the therapeutic front, Amarantus is advancing Eltoprazine, a small molecule drug targeting both Levadopa-Induced Dyskinesia in Parkinson's patients and attention deficit hyperactivity disorders (ADHD). Additionally, they are developing a mesencephalic-astrocyte-derived neurotrophic factor (MANF) for treating conditions modeled in animals, such as retinitis pigmentosa and retinal artery occlusion. Amarantus also maintains several specialized platforms: NuroPro, a diagnostic platform dedicated to neurodegenerative diseases with an initial application in Parkinson's; BC-SeraPro, an oncology diagnostic platform specifically for breast cancer; and the PhenoGuard platform, designed for discovering new neurotrophic factors. Beyond these, the company is progressing with Engineered Skin Substitute (ESS), a cell therapy-based product for autologous skin replacement, currently in mid-stage clinical development for severe, life-threatening burns. The company has established a collaborative research and development agreement with both the U.S. Army Institute of Surgical Research and Rutgers University. Established in 2008, Amarantus BioScience Holdings, Inc., which previously operated as Amarantus Bioscience, Inc. until its name change in April 2013, is headquartered in New York, New York.
Aktiekurs
$0.0001
Senast synkroniserad: 2026-08-12
Marknadsvärde
$36.84K
Förändring (1 dag)
0.00%
Förändring (1 år)
-66.67%
Land
US
Handel Amarantus BioScience Holdings, Inc. (AMBS)

Kategori

Healthcare
Utdelningshistorik för Amarantus BioScience Holdings, Inc. (AMBS)
Amarantus BioScience Holdings, Inc. (aktiens symbol: AMBS) har gjort totalt 0 utdelningsbetalningar.
Summan av alla utdelningar (justerat för aktiesplitar) är: 0.00
Utdelningsavkastning (TTM): 0
Utdelningsbetalningar för Amarantus BioScience Holdings, Inc. (AMBS) från 2026 till 2026
Årliga utdelningsbetalningar
År Utdelning (justerat för aktiesplitar) Ändra
Inte tillräckligt med data för de angivna datumen.
Lista över alla utdelningsbetalningar
År Utdelning Ändra
Inte tillräckligt med data för de angivna datumen.
Utdelningar för liknande företag eller konkurrenter
Företag Antal utdelningsbetalningar Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
0.00%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
29.00%
BE